These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 12821499)
1. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Wagner J; Jabbusch M; Eisenblätter M; Hahn H; Wendt C; Ignatius R Antimicrob Agents Chemother; 2003 Jul; 47(7):2358-61. PubMed ID: 12821499 [TBL] [Abstract][Full Text] [Related]
2. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results. Ruckdeschel G; Dalhoff A J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872 [TBL] [Abstract][Full Text] [Related]
3. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method]. Žemličková H; Jakubů V; Marejková M; Urbášková P Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481 [TBL] [Abstract][Full Text] [Related]
4. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. Gaudreau C; Gilbert H J Antimicrob Chemother; 1997 Jun; 39(6):707-12. PubMed ID: 9222038 [TBL] [Abstract][Full Text] [Related]
5. In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001. Krausse R; Ullmann U Antimicrob Agents Chemother; 2003 Sep; 47(9):2946-50. PubMed ID: 12936999 [TBL] [Abstract][Full Text] [Related]
6. Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae. Reinert RR; Schlaeger JJ; Lütticken R J Antimicrob Chemother; 1998 Dec; 42(6):803-6. PubMed ID: 10052905 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad. Rautelin H; Vierikko A; Hänninen ML; Vaara M Antimicrob Agents Chemother; 2003 Jan; 47(1):102-5. PubMed ID: 12499176 [TBL] [Abstract][Full Text] [Related]
8. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. Kayman T; Abay S; Aydin F; Şahin O J Med Microbiol; 2019 Feb; 68(2):136-142. PubMed ID: 30540246 [TBL] [Abstract][Full Text] [Related]
10. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. Speciale A; Musumeci R; Blandino G; Milazzo I; Caccamo F; Nicoletti G Int J Antimicrob Agents; 2002 Feb; 19(2):111-8. PubMed ID: 11850163 [TBL] [Abstract][Full Text] [Related]
11. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics]. García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolates obtained in Montreal, Quebec, Canada, from 2002 to 2013. Gaudreau C; Boucher F; Gilbert H; Bekal S J Clin Microbiol; 2014 Jul; 52(7):2644-6. PubMed ID: 24759726 [TBL] [Abstract][Full Text] [Related]